-
ACLA Statement on Year-End Funding Package
WASHINGTON, D.C. – As Congress nears a vote on year-end legislation to fund the government and support COVID-19 response efforts, ACLA President Julie Khani released the following ... Read More -
ACLA Statement on COVID-19 Vaccine Approval
Washington, D.C. – Following the Food and Drug Administration’s (FDA) emergency use authorization (EUA) of a COVID-19 vaccine, ACLA President Julie Khani issued the following statement: “With ... Read More -
ACLA Update on PCR Testing Capacity For COVID-19
WASHINGTON, D.C. – As COVID-19 cases continue to surge across the United States, ACLA President Julie Khani issued the following statement: “Yesterday, ACLA member laboratories collectively performed 495,000 ... Read More -
ACLA Update on PCR Testing Capacity For COVID-19
WASHINGTON, D.C. – As COVID-19 cases continue to surge across the United States, ACLA President Julie Khani issued the following statement: “Yesterday, ACLA member laboratories collectively ... Read More -
ACLA Statement on Key Priorities for the Incoming Biden Administration, New Congress
WASHINGTON, D.C. – Following the election of former Vice President Joe Biden, ACLA President Julie Khani issued the following statement: “ACLA and its members congratulate ... Read More -
ACLA Statement on CMS Policy: Cutting lab reimbursement won’t address the root causes of delayed turnaround times
Washington, D.C. – Following today’s announcement by Centers for Medicare & Medicaid Services (CMS) on Medicare reimbursement rates for COVID-19 testing, ACLA President Julie Khani ... Read More -
ACLA Statement on FDA Announcement Regarding EUA Reviews
Washington, D.C. – Following the recent FDA decision to no longer review emergency use authorizations (EUAs) for lab-developed COVID-19 testing, ACLA President Julie Khani released ... Read More -
ACLA Statement on Recent HHS Announcement Regarding Regulation of Laboratory Developed Tests
Washington, D.C. – Following the recent announcement from the U.S. Department of Health and Human Services (HHS) that the U.S. Food and Drug Administration (FDA) ... Read More -
Patients, Employers, Labs and Health Insurance Providers Call on Congress to Dedicate Funding for COVID-19 Testing to Get America Back to Work and School
WASHINGTON, D.C. – The National Consumers League, the American Clinical Laboratory Association (ACLA) and America’s Health Insurance Plans (AHIP) joined nearly 50 leading stakeholders representing ... Read More -
ACLA Update on PCR Testing Capacity for COVID-19
WASHINGTON, D.C. – As ACLA member laboratories continue to navigate unprecedented demand and significant supply challenges, ACLA President Julie Khani issued the following statement: “In ... Read More
